ASBP

Conviction 89HealthcareScan · Tue, Sep 8, 2026

Bearish engulfing

ASBP$8.87-4.11%

ResistanceSupportVol 14

Vol MA14 29.26K

Jun 8Jun 25Jul 15Jul 31Aug 19Sep 4

Aspire Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.aspirebiolabs.com ↗

Price8.87

Change-4.11%

Gap+0.00%

Rel volume1.43×

Avg volume30.25K

Avg $ vol248.49K

SMA 208.15

SMA 507.16

SMA 2003.16

Price vs 50+23.83%

Price vs 200+180.74%

MA stackbullish

50/200 cross—

Supertrendup · 7.60

RSI (14)63

MACD hist0.06

MACD cross—

Stoch %K / %D68 / 85

ADX (14)21

+DI / −DI22 / 13

RSI divergenceBearish

MACD divergenceBearish

ATR %+6.69%

ADR %6.60%

52w high9.25

52w low0.0519

From 52w high-4.11%

Above 52w low+16990.56%

New 52w highNo

SqueezeOff

Bollinger width30.42%

%B0.79

Donchian pos74.18%

Donchian high9.50

Donchian low7.06

AVWAP (52w high)9.06

vs AVWAP high-2.06%

AVWAP (52w low)0.4343

vs AVWAP low+1942.52%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d1.43×

Avg vol (14d)29.26K

Avg vol (20d)30.25K

Avg $ vol (20d)248.49K

Market cap12.44M

RS 3m (vs SPY)+61.68%

RS 6m (vs SPY)+650.11%

RS line new highNo

Trend template8/8

Technical rank93.3

1 week+4.23%

1 month+25.64%

3 months+66.10%

6 months+664.66%

1 year+1528.12%

YTD+6379.18%

P/E-0.51

P/B1.06

P/S—

P/FCF—

EPS-16.38

Div yield—

ROE-208.21%

ROA-180.80%

Debt/Eq—

Current7.99

EV/EBITDA—

Gross margin-1.87%

Net margin—

Rev growth—

EPS growth-1768.95%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value273.54K

Revenue28.35K

Net income-1.27M

Gross profit-30.09K

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.3M

Employees—

ListedThu, Feb 20, 2025

Free float4.51M

Float %89.7%

Short interest66.08K

Days to cover2.1d

Short volume12.5%

Squeeze score20 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction89 / 100

Pattern quality—

Tech rank93.3 / 100

Group rank96 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ASBP

All disclosures →

No recent disclosed trades by Congress in ASBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ASBP

No recent insider (Form 4) filings in ASBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ASBP · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.